Skip to main content
. 2019 Jul 5;11(7):318. doi: 10.3390/pharmaceutics11070318

Figure 3.

Figure 3

Mean arterial plasma concentration-time profiles of tofacitinib in Sprague-Dawley rats after (A) 30-min intravenous (n = 7) and intraportal (n = 7) infusions of 10 mg/kg tofacitinib and (B) 30-min intraportal (n = 6) infusion, and intraduodenal (n = 5) and intragastric (n = 5) instillations of 10 mg/kg tofacitinib. Bars represent standard deviations (SD).